Literature DB >> 26095370

The Relationship Between Depressive Symptoms and Self-Management Behaviors in Patients With T2DM and Stage 3 CKD.

Teresa J Sakraida1, Mary T Weber2.   

Abstract

PURPOSE: This study aimed to assess the relationship of depressive symptoms with self-management by adults with type 2 diabetes mellitus and chronic kidney disease. DESIGN AND METHODS: Using a descriptive correlational design, participants completed Beck's Depression Inventory (BDI-II) and Summary of Diabetes Self-Care Activities measure.
FINDINGS: Reported were energy loss, sleep change, and fatigue. Performed less were exercise, physical activity, eating vegetables, and blood checks. Significant correlations were BDI-II total score with feet checking, energy loss with feet checking and exercise, and sleep change with feet soaking. PRACTICE IMPLICATIONS: Depressive symptoms were associated to self-management behaviors that require physical energy. Assess for advancing symptoms.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chronic kidney disease; depression; self-care; self-management; type 2 diabetes

Mesh:

Year:  2015        PMID: 26095370     DOI: 10.1111/ppc.12128

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  3 in total

1.  Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Authors:  Alla Sikorskii; Charles W Given; Barbara A Given; Asish Banik; John C Krauss
Journal:  Ann Behav Med       Date:  2020-06-12

Review 2.  Applying A Biopsychosocial Framework to Achieve Durable Behavior Change in Kidney Disease.

Authors:  Devika Nair; Daniel Cukor; Warren D Taylor; Kerri L Cavanaugh
Journal:  Semin Nephrol       Date:  2021-11       Impact factor: 5.299

3.  Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabetes Mellitus.

Authors:  Ewelina Bąk; Ewa Marcisz-Dyla; Agnieszka Młynarska; Danuta Sternal; Monika Kadłubowska; Czesław Marcisz
Journal:  Patient Prefer Adherence       Date:  2020-03-03       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.